{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:40:40Z","timestamp":1790217640173,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.pdpdt.2026.105360","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:19:50Z","timestamp":1769271590000},"page":"105360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Real-world outcomes of photoimmunotherapy for oral sites in head and neck cancer: A multicentre subgroup analysis"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1315-5813","authenticated-orcid":false,"given":"On","family":"Hasegawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaku","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiomi","family":"Kushihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Masubuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Tokashiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoaki","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2026.105360_bib0001","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0002","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"KEYNOTE-048 investigators, pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.pdpdt.2026.105360_bib0003","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0004","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3390\/cancers17162671","article-title":"Real-world effectiveness and safety of photoimmunotherapy for head and neck cancer: a multicenter retrospective study","volume":"17","author":"Okamoto","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.pdpdt.2026.105360_bib0005","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1007\/s10147-021-01960-6","article-title":"A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma","volume":"26","author":"Tahara","year":"2021","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0006","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1002\/hed.26885","article-title":"Phase 1\/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma","volume":"43","author":"Cognetti","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.pdpdt.2026.105360_bib0007","doi-asserted-by":"crossref","first-page":"2","DOI":"10.6004\/jnccn.2025.0007","article-title":"NCCN Guidelines\u00ae insights: head and neck cancers, version 2.2025","volume":"23","author":"Colevas","year":"2025","journal-title":"J. Natl Compr. Canc. Netw."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2025.104719","article-title":"Near-infrared photoimmunotherapy for recurrent cancer at the base of the tongue","volume":"54","author":"Makino","year":"2025","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0009","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.3390\/cancers14184413","article-title":"Quality-of-life evaluation of patients with unresectable locally advanced or locally recurrent head and neck carcinoma treated with head and neck photoimmunotherapy","volume":"14","author":"Okamoto","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pdpdt.2026.105360_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.21873\/cdp.10428","article-title":"Predictive factors for the efficacy of head and neck photoimmunotherapy and optimization of treatment schedules","volume":"5","author":"Nishikawa","year":"2025","journal-title":"Cancer Diagn. Progn."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0011","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1021\/acs.accounts.9b00273","article-title":"Near-infrared photoimmunotherapy of cancer","volume":"52","author":"Kobayashi","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0013","series-title":"Common Terminology Criteria For Adverse Events (CTCAE), Version 5.0","year":"2017"},{"key":"10.1016\/j.pdpdt.2026.105360_bib0014","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0015","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/hed.21368","article-title":"Temoporfin-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study","volume":"32","author":"Tan","year":"2010","journal-title":"Head Neck"},{"key":"10.1016\/j.pdpdt.2026.105360_bib0016","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/odi.14471","article-title":"Multicenter retrospective study of nivolumab for recurrent\/metastatic oral squamous cell carcinoma","volume":"30","author":"Yamakawa","year":"2024","journal-title":"Oral Dis."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0017","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ohn.1088","article-title":"Neutrophil-to-lymphocyte ratio and pembrolizumab outcomes in oral cavity squamous cell carcinoma","volume":"172","author":"Truong","year":"2025","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0018","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00280-018-3531-x","article-title":"Multicenter retrospective study of cetuximab plus platinum-based chemotherapy for recurrent or metastatic oral squamous cell carcinoma","volume":"81","author":"Yanamoto","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0019","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3892\/ol.2024.14486","article-title":"Firstline programmed cell death 1 inhibitor plus chemotherapy vs. standard treatment in patients with recurrent or metastatic oral squamous cell carcinoma: a retrospective cohort study","volume":"28","author":"Cheng","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0020","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3390\/healthcare11060924","article-title":"A case series on pain accompanying photoimmunotherapy for head and neck cancer","volume":"11","author":"Shibutani","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.pdpdt.2026.105360_bib0021","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/nm.2554","article-title":"Cancer cell\u2013selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules","volume":"17","author":"Mitsunaga","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0022","doi-asserted-by":"crossref","first-page":"35069","DOI":"10.18632\/oncotarget.17047","article-title":"Near-infrared photoimmunotherapy: a comparison of light dosing schedules","volume":"8","author":"Ogata","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pdpdt.2026.105360_bib0023","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s11307-023-01822-9","article-title":"In vivo imaging of acute physiological responses after treatment of cancer with near-infrared photoimmunotherapy","volume":"25","author":"Nakajima","year":"2023","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0024","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ajoms.2025.01.006","article-title":"Histopathological analysis of tumor microenvironmental changes after near-infrared photoimmunotherapy","volume":"37","author":"Chida","year":"2025","journal-title":"J. Oral Maxillofac. Surg. Med. Pathol."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0025","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/lary.30157","article-title":"Carotid blowout syndrome in head and neck cancer patients: management of patients at risk for CBS","volume":"133","author":"Slijepcevic","year":"2023","journal-title":"Laryngoscope"},{"key":"10.1016\/j.pdpdt.2026.105360_bib0026","first-page":"5557","article-title":"Immediate post-treatment supportive care needs of patients newly diagnosed with head and neck cancer","volume":"28","author":"Henry","year":"2020","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.pdpdt.2026.105360_bib0027","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.clnu.2013.06.012","article-title":"Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo)radiotherapy: a systematic review","volume":"32","author":"Langius","year":"2013","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0028","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/CCO.0000000000001135","article-title":"New trends in supportive care of head and neck cancers","volume":"37","author":"Mascagni","year":"2025","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0029","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.21873\/anticanres.17218","article-title":"Feasibility of near-infrared photoimmunotherapy combined with immune checkpoint inhibitor therapy in unresectable head and neck cancer","volume":"44","author":"Hirakawa","year":"2024","journal-title":"Anticancer Res."},{"key":"10.1016\/j.pdpdt.2026.105360_bib0030","series-title":"Initiation of the Eclipse Trial (ASP-1929-381, jRCT2061250025) Evaluating ASP-1929 Photoimmunotherapy Plus Pembrolizumab in Head and Neck Cancer","year":"2021"}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157210002600027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157210002600027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:16:55Z","timestamp":1789629415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157210002600027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":29,"alternative-id":["S157210002600027X"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105360","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world outcomes of photoimmunotherapy for oral sites in head and neck cancer: A multicentre subgroup analysis","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105360"}}